Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,628 studies match

clinicaltrialsPublishedShowing 701–750 of 2,628 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05933577	A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)	active not recruiting	Phase 3	1,089	Merck Sharp & Dohme LLCINDUSTRY	26	Sep 24, 2025	clinicaltrials
NCT03731260	(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis	active not recruiting	Phase 2	251	Blueprint Medicines CorporationINDUSTRY	13